𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alkylating agents as leukemogens in multiple myeloma

✍ Scribed by Richard K. Karchmer; Mammo Amare; William E. Larsen; Alexander G. Mallouk; Glyn G. Caldwell

Book ID
101323684
Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
447 KB
Volume
33
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Alkylating agents induce activation of N
Alkylating agents induce activation of NFΞΊB in multiple myeloma cells
✍ Philipp Baumann; Sonja Mandl-Weber; Fuat Oduncu; Ralf Schmidmaier πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 252 KB

Multiple myeloma is still not curable and drug combination strategies are currently being evaluated in order to achieve high remission rates with tolerable toxicity. Bortezomib has been shown to exert inhibitory effects on NFB activity. NFB in turn is known to be activated by cytokines, growth facto

Salvage treatment for patient with multi
Salvage treatment for patient with multiple myeloma refractory to alkylating agents
✍ Gomez, German A. ;Han, Tin ;Ozer, Howard ;Henderson, Edward S. πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 455 KB

Sixteen patients with multiple myeloma refractory to alkylating agents were treated with vincristine 0.25 mg/m2 i.v. on days 1 to 4 and prednisone 1 gm/m2 on days 1 and 3. Chemotherapy was repeated every 2 weeks. Of 15 evaluable patients, five achieved a partial response and four stable disease. Thr